MAPT and amyotrophic lateral sclerosis: The main strengths of our study are its multicentric nature and the detailed clinical characterisation of a large proportion of ALS cases, as well as the use of different biospecimens (serum, CSF and muscle biopsy) and techniques (ultrasensitive ELISAs, IHC and MS) to investigate p-tau species.